Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.35 USD | +3.21% | -1.42% | +52.37% |
04-18 | ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing | MT |
04-18 | ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing | MT |
Sales 2024 * | 5.54M 444M | Sales 2025 * | 85.45M 6.84B | Capitalization | 809M 64.77B |
---|---|---|---|---|---|
Net income 2024 * | -59M -4.72B | Net income 2025 * | -35M -2.8B | EV / Sales 2024 * | 120 x |
Net cash position 2024 * | 141M 11.32B | Net cash position 2025 * | 144M 11.55B | EV / Sales 2025 * | 7.78 x |
P/E ratio 2024 * |
-13.7
x | P/E ratio 2025 * |
-24.3
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.22% |
1 day | +3.21% | ||
1 week | -1.42% | ||
Current month | -18.30% | ||
1 month | -16.16% | ||
3 months | +32.86% | ||
6 months | +140.63% | ||
Current year | +52.37% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 8.35 | +3.21% | 520,298 |
25/04/24 | 8.09 | -2.06% | 534,709 |
24/04/24 | 8.26 | -2.82% | 334,679 |
23/04/24 | 8.5 | +3.53% | 510,439 |
22/04/24 | 8.21 | -3.07% | 394,656 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.37% | 809M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SPRY Stock